Granted Patent
B2
US 8,455,549 · App. 12/674,746 · Granted Jun 4, 2013
Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
Assignee:
Aniona Aps
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to the use of a particular group of carbonylamino derivatives for the treatment or alleviation of a disease or condition relating to certain inflammatory disorders.
Claims (1)
1. A method for the treatment or alleviation of an inflammatory bowel disease selected from the group consisting of ulcerative colitis and Crohn's disease, which method comprises the step of administering to a living animal body in need thereof a therapeutically effective amount ranging from 0.3 mg/kg to 3 mg/kg of 2,2-bis-(4-fluorophenyl)-3-methylbutyramide or a pharmaceutically-acceptable addition salt thereof.
Assignments (4)
CHANGE OF ADDRESS OF ASSIGNEE
Recorded Oct 21, 2020
From: SANIONA A/S
To: SANIONA A/S
Reel/Frame 054396/0996 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 20, 2013
From: NEUROSEARCH A/S
To: ANIONA APS
Reel/Frame 030049/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 28, 2010
From: MADSEN, LARS SIIM; CHRISTOPHERSEN, PALLE
To: NEUROSEARCH A/S
Reel/Frame 024149/0001 →
Priority Claims (1)
DK 2007 01211
· Aug 24, 2007
· national
Continuity (2)
Provisional Application
60957811
· Aug 24, 0207